Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...

A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...

Small business owners need an efficient, accurate invoicing system to ensure they’re paid promptly. The easier it is to set up and send invoices, the better your chances of staying on top of accounts ...

In the years following, ships transported at least 400,000 slaves from Africa to ports in New England and the southern states. Their free labor allowed the tobacco, cotton, and sugar industires to ...

There comes a time before every big purchase when you might ask yourself, “Do I really need this?” If you don’t pause for a moment — and if you tend to blow your budget as a result — then you need to ...

Discover the best invoice software solutions tailored for any business size, offering a range of features from free plans to advanced tools. Here are the best invoicing software options that offer ...

Troy Segal is an editor and writer. She has 20+ years of experience covering personal finance, wealth management, and business news. David Kindness is a Certified Public Accountant (CPA) and an expert ...

Chart Industries and Flowserve recently agreed to merge in an all-stock deal. The two companies outlined significant revenue and cost synergies. Strangely, both bargain-priced stocks fell after the ...

Chart Industries (NYSE:GTLS) and Flowserve (NYSE:FLS) said Wednesday they agreed to combine in an all-stock merger valued at ~$19B including debt, creating a differentiated leader in industrial ...